Publications by authors named "Michael Slade"

Claim this Profile
C
Convenience Versus Continuity: A Pilot Study of Care Transfer to a Satellite Clinic for Patients With Plasma Cell Dyscrasias.
Angela M Vickroy, Margaret Kavanaugh, Jordan Smith, Carmen A Wilson, Keith Stockerl-Goldstein, Michael J Slade

Cancer Control· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate E-Selectin Inhibition with Uproleselan to Reduce Gastrointestinal Toxicity During Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
Zachary D Crees, Keith Stockerl-Goldstein, Meaghan Ryan, Feng Gao, Brandon Christen, Michael J Slade

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-Based Measurable Residual Disease by Clonotypic Mass Spectrometry is Prognostic in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant.
Michael J Slade, Julie Fortier, Abir Khaled, Mark Fiala, Zac McDonald

Clin Lymphoma Myeloma Leuk· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Deductible Health Plans and Out-of-Pocket Health Care Costs Among Younger Patients With Multiple Myeloma.
Mark Aaron Fiala, Mengmeng Ji, Michael Slade, John H Huber, Yi-Hsuan Shih

JCO Oncol Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Episteme.
Michael J Slade

J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma.
Alice Y Zhou, Nancy D Marin, Sadia Afrin, Pamela Wong, Jennifer Tran, Michael Slade

J Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces equivalent outcomes to patients with no donor specific antibodies in haploidentical hematopoietic cell transplant.
Hunter Cassidy Cochran, Michael Joseph Slade, Chang Liu, Feng Gao, Sonia Godbole

Leuk Lymphoma· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors.
Ju-Fang Chang, Jack H Landmann, Tien-Ching Chang, Mehmet Emrah Selli, Yangdon Tenzin, Michael Slade

Cancer Discov· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma.
Scott R Goldsmith, Michael J Slade, Mark Fiala, Melinda Harding, Zachary D Crees

Ann Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False-positive human immunodeficiency virus nuclear acid amplification technique testing following therapy with transgenic T cell receptor cellular therapy for synovial sarcoma.
Michael Slade, Dejka Araujo, Min Du, Bijal Parikh, Neil Anderson

Bone Marrow Transplant· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma.
William C Pilcher, Lijun Yao, Edgar Gonzalez-Kozlova, Yered Pita-Juarez, Dimitra Karagkouni, Michael Slade

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretransplant Desensitization of Donor-Specific Anti-HLA Antibodies with Plasmapheresis and Immunoglobulin Produces Equivalent Outcomes to Patients with No Donor Specific Antibodies in Haploidentical Hematopoietic Cell Transplant.
Hunter Cochran, Michael Slade, Feng Gao, Sonia Godbole, Aaron Pruitt

Res Sq· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial.
Michael Slade, Mark A Fiala, Marie Kirchmeyer, Jeff King, Feng Gao

Transplant Cell Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and Dexamethasone.
Alexa J Loncharich, Mark A Fiala, Michael J Slade, Angela Vickroy, Margaret Kavanaugh

Clin Lymphoma Myeloma Leuk· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cycles.
Michael J Slade

JAMA Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G Karrison, Michael J Slade

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of donor age and relationship on outcomes of peripheral blood haploidentical hematopoietic cell transplantation.
Aaron Pruitt, Feng Gao, Elisa De Togni, Hunter Cochran, Sonia Godbole, Michael Slade

Bone Marrow Transplant· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction.
Mehmet Emrah Selli, Jack H Landmann, Marina Terekhova, John Lattin, Amanda Heard, Michael Slade

Blood· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single Reference Interval for Interpreting Serum Free Light Chains across Patients with Varying Renal Function.
Vahid Azimi, Michael Slade, Mark Fiala, Julie M Fortier, Keith Stockerl-Goldstein

Clin Chem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Simplified Score to Predict Early Relapse in Multiple Myeloma (S-ERMM) in the MMRF CoMMpass study.
Michael Slade, Mark Fiala, Sarah Kelley, Zachary D Crees, Mark A Schroeder

Leuk Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent Molecular Disease in Adult Patients With AML Evaluated With Whole-Exome and Targeted Error-Corrected DNA Sequencing.
Michael J Slade, Reza Ghasemi, Michelle O'Laughlin, Tasha Burton, Robert S Fulton

JCO Precis Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction.
Mehmet Emrah Selli, Jack H Landmann, Marina Terekhova, John Lattin, Amanda Heard, Michael Slade

bioRxiv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of tocilizumab treatment for cytokine release syndrome on the incidence of early blood stream infections after peripheral blood haploidentical hematopoietic cell transplantation.
Elisa De Togni, Fei Wan, Michael Slade, Kelly Plach, Ramzi Abboud

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma.
Michael Slade, Thomas G Martin, Nitya Nathwani, Mark A Fiala, Michael P Rettig

Leukemia· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis.
Armin Ghobadi, Michael Slade, Hagop Kantarjian, Julio Alvarenga, Ibrahim Aldoss

Blood· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis